Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Industrials Conglomerates
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Advanced Proteome Therapeutics Corporation
Bullboard Posts
User Avatar Image
(6)
•••
Post by Mikeylikesit92on Apr 20, 2018 11:36am
69 Views
Post# 27917624

news on amanitin animal studies soon

news on amanitin animal studies soonnews will be released on amanitin warhead ATAC animal trials almost done this could be big for apc also there is a deal in the works with Kadcyla which is gonna be huge but the amanitin deal with Heidelberg Pharma will change prostate cancer treatment and apc is gonna be the one making these conjugates big big upside with fda aproval of a-amanitin warhead big upside get in on these cheap shares 1 news release away from ytd high.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities